Inhaltsbereich
| 43 Einträge | 1, 2, 3 › » |
Seite 1 / 3
 Druckansicht
|
| Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead. |
| Goodson WH, Lowe L, Carpenter DO, Gilbertson M, Manaf Ali A, Lopez de Cerain Salsamendi A, Lasfar A, Carnero A, Azqueta A, Amedei A, Charles AK, Collins AR, Ward A, Salzberg AC, Colacci A, Olsen AK, Berg A, Barclay BJ, Zhou BP, Blanco-Aparicio C, Baglole CJ, Dong C, Mondello C, Hsu CW, Naus CC, Yedjou C, Curran CS, Laird DW, Koch DC, Carlin DJ, Felsher DW, Roy D, Brown DG, Ratovitski E, Ryan EP, Corsini E, Rojas E, Moon EY, Laconi E, Marongiu F, Al-Mulla F, Chiaradonna F, Darroudi F, Martin FL, Van Schooten FJ, Goldberg GS, Wagemaker G, Nangami GN, Calaf GM, Williams G, Wolf GT, Koppen G, Brunborg G, Lyerly HK, Krishnan H, Ab Hamid H, Yasaei H, Sone H, Kondoh H, Salem HK, Hsu HY, Park HH, Koturbash I, Miousse IR, Scovassi AI, Klaunig JE, Vondráček J, Raju J, Roman J, Wise JP, Whitfield JR, Woodrick J, Christopher JA, Ochieng J, Martinez-Leal JF, Weisz J, Kravchenko J, Sun J, Prudhomme KR, Narayanan KB, Cohen-Solal KA, Moorwood K, Gonzalez L, Soucek L, Jian L, D'Abronzo LS, Lin LT, Li L, Gulliver L, McCawley LJ, Memeo L, Vermeulen L, Leyns L, Zhang L, Valverde M, Khatami M, Romano MF, Chapellier M, Williams MA, Wade M, Manjili MH, Lleonart ME, Xia M, Gonzalez MJ, Karamouzis MV, Kirsch-Volders M, Vaccari M, Kuemmerle NB, Singh N, Cruickshanks N, Kleinstreuer N, van Larebeke N, Ahmed N, Ogunkua O, Krishnakumar PK, Vadgama P, Marignani PA, Ghosh PM, Ostrosky-Wegman P, Thompson PA, Dent P, Heneberg P, Darbre P, Sing Leung P, Nangia-Makker P, Cheng QS, Robey RB, Al-Temaimi R, Roy R, Andrade-Vieira R, Sinha RK, Mehta R, Vento R, Di Fiore R, Ponce-Cusi R, Dornetshuber-Fleiss R, Nahta R, Castellino RC, Palorini R, Abd Hamid R, Langie SA, Eltom SE, Brooks SA, Ryeom S, Wise SS, Bay SN, Harris SA, Papagerakis S, Romano S, Pavanello S, Eriksson S, Forte S, Casey SC, Luanpitpong S, Lee TJ, Otsuki T, Chen T, Massfelder T, Sanderson T, Guarnieri T, Hultman T, Dormoy V, Odero-Marah V, Sabbisetti V, Maguer-Satta V, Rathmell WK, Engström W, Decker WK, Bisson WH, Rojanasakul Y, Luqmani Y, Chen Z, Hu Z |
| Carcinogenesis. 2015 Jun 24. pii: bgv039. doi: 10.1093/carcin/bgv039. pmc: PMC4480130 |
| PMID: 26106142 |
| Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis. |
| Kirschner MB, Pulford E, Hoda MA, Rozsas A, Griggs K, Cheng YY, Edelman JJ, Kao SC, Hyland R, Dong Y, László V, Klikovits T, Vallely MP, Grusch M, Hegedus B, Dome B, Klepetko W, van Zandwijk N, Klebe S, Reid G |
| British journal of cancer. 2015 Aug 11. pii: bjc2015286. doi: 10.1038/bjc.2015.286 |
| PMID: 26263483 |
| Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia. |
| Grebien F, Vedadi M, Getlik M, Giambruno R, Grover A, Avellino R, Skucha A, Vittori S, Kuznetsova E, Smil D, Barsyte-Lovejoy D, Li F, Poda G, Schapira M, Wu H, Dong A, Senisterra G, Stukalov A, Huber KV, Schönegger A, Marcellus R, Bilban M, Bock C, Brown PJ, Zuber J, Bennett KL, Al-Awar R, Delwel R, Nerlov C, Arrowsmith CH, Superti-Furga G |
| Nature chemical biology. 2015 Jul 13. pii: nchembio.1859. doi: 10.1038/nchembio.1859. pmc: PMC4511833. mid: EMS63643 |
| PMID: 26167872 |
| Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma. |
| Laszlo V, Hoda MA, Garay T, Pirker C, Ghanim B, Klikovits T, Dong YW, Rozsas A, Kenessey I, Szirtes I, Grusch M, Jakopovic M, Samarzija M, Brcic L, Kern I, Rozman A, Popper H, Zöchbauer-Müller S, Heller G, Altenberger C, Ziegler B, Klepetko W, Berger W, Dome B, Hegedus B |
| The Journal of pathology. 2015 May 26. doi: 10.1002/path.4567 |
| PMID: 26011651 |
| High EMT Signature Score of Invasive Non-Small Cell Lung Cancer (NSCLC) Cells Correlates with NFκB Driven Colony-Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts. |
| Rudisch A, Dewhurst MR, Horga LG, Kramer N, Harrer N, Dong M, van der Kuip H, Wernitznig A, Bernthaler A, Dolznig H, Sommergruber W |
| PloS one. 2015 Apr 28. doi: 10.1371/journal.pone.0124283. pii: PONE-D-14-36672. pmc: PMC4412534 |
| PMID: 25919140 |
| A comparative PET imaging study with the reversible and irreversible EGFR tyrosine kinase inhibitors [(11)C]erlotinib and [(18)F]afatinib in lung cancer-bearing mice. |
| Slobbe P, Windhorst AD, Stigter-van Walsum M, Smit EF, Niessen HG, Solca F, Stehle G, van Dongen GA, Poot AJ |
| EJNMMI research. 2015 Mar 20. doi: 10.1186/s13550-015-0088-0. pii: 88. pmc: PMC4385286 |
| PMID: 25853020 |
| Development of [18F]afatinib as new TKI-PET tracer for EGFR positive tumors. |
| Slobbe P, Windhorst AD, Stigter-van Walsum M, Schuit RC, Smit EF, Niessen HG, Solca F, Stehle G, van Dongen GA, Poot AJ |
| Nuclear medicine and biology. 2014 Jun 25. pii: S0969-8051(14)00430-2. doi: 10.1016/j.nucmedbio.2014.06.005 |
| PMID: 25066021 |
| T-cell receptor Vβ skewing frequently occurs in refractory cytopenia of childhood and is associated with an expansion of effector cytotoxic T cells: a prospective study by EWOG-MDS. |
| Aalbers AM, van den Heuvel-Eibrink MM, Baumann I, Beverloo HB, Driessen GJ, Dworzak M, Fischer A, Göhring G, Hasle H, Locatelli F, De Moerloose B, Noellke P, Schmugge M, Stary J, Yoshimi A, Zecca M, Zwaan CM, van Dongen JJ, Pieters R, Niemeyer CM, van der Velden VH, Langerak AW |
| Blood cancer journal. 2014 May 2. pii: bcj201428. doi: 10.1038/bcj.2014.28. pmc: PMC4042298 |
| PMID: 24786393 |
| The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood: a prospective study by EWOG-MDS. |
| Aalbers AM, van der Velden VH, Yoshimi A, Fischer A, Noellke P, Zwaan CM, Baumann I, Beverloo HB, Dworzak M, Hasle H, Locatelli F, De Moerloose B, Göhring G, Schmugge M, Stary J, Zecca M, Langerak AW, van Dongen JJ, Pieters R, Niemeyer CM, van den Heuvel-Eibrink MM |
| Leukemia. 2013 Jun 28. pii: leu2013195. doi: 10.1038/leu.2013.195 |
| PMID: 23807769 |
| MicroRNA-300 inhibited glioblastoma progression through ROCK1. |
| Zhou F, Li Y, Hao Z, Liu X, Chen L, Cao Y, Liang Z, Yuan F, Liu J, Wang J, Zheng Y, Dong D, Bian S, Yang B, Jiang C, Li Q |
| Oncotarget. 2016 Apr 28. pii: 9068. doi: 10.18632/oncotarget.9068 |
| PMID: 27145462 |
| Estimation of (99)Mo production rates from natural molybdenum in research reactors. |
| Blaauw M, Ridikas D, Baytelesov S, Salas PS, Chakrova Y, Eun-Ha C, Dahalan R, Fortunato AH, Jacimovic R, Kling A, Muñoz L, Mohamed NM, Párkányi D, Singh T, Van Dong Duong |
| Journal of radioanalytical and nuclear chemistry. 2016 Sep 24. doi: 10.1007/s10967-016-5036-6. pii: 5036 |
| PMID: 28111485 |
| Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study. |
| Hoda MA, Dong Y, Rozsas A, Klikovits T, Laszlo V, Ghanim B, Stockhammer P, Ozsvar J, Jakopovic M, Samarzija M, Brcic L, Bendek M, Szirtes I, Reid G, Kirschner MB, Kao SC, Opitz I, Weder W, Frauenfelder T, Nguyen-Kim TD, Aigner C, Klepetko W, van Zandwijk N, Berger W, Dome B, Grusch M, Hegedus B |
| European journal of cancer (Oxford, England : 1990). 2016 Jun 8. pii: S0959-8049(16)32116-5. doi: 10.1016/j.ejca.2016.04.018 |
| PMID: 27288871 |
| Management of malignant pleural mesothelioma - part 3 : Data from the Austrian Mesothelioma Interest Group (AMIG) database. |
| Klikovits T, Hoda MA, Dong Y, Arns M, Baumgartner B, Errhalt P, Geltner C, Machan B, Pohl W, Hutter J, Eckmayr J, Studnicka M, Flicker M, Cerkl P, Kirchbacher K, Klepetko W |
| Wiener klinische Wochenschrift. 2016 Jul 25. doi: 10.1007/s00508-016-1037-2. pii: 10.1007/s00508-016-1037-2 |
| PMID: 27457873 |
| Trabectedin is active against malignant pleural mesothelioma cell and xenograft models and synergizes with chemotherapy and bcl-2 inhibition in vitro. |
| Hoda MA, Pirker C, Dong Y, Schelch K, Heffeter P, Kryeziu K, van Schoonhoven S, Klikovits T, Laszlo V, Rozsas A, Ozsvar J, Klepetko W, Doeme B, Grusch M, Hegedues B, Berger W |
| Molecular cancer therapeutics. 2016 Aug 10. pii: 1535-7163.MCT-15-0846. doi: 10.1158/1535-7163.MCT-15-0846 |
| PMID: 27512118 |
| Caution in Generalizing the Use of Adjunctive Primary Corticosteroids in Kawasaki Disease to Unselected Non-Japanese Populations-Reply. |
| Dong Y, Chen S |
| JAMA pediatrics. 2017 Feb 20. pii: 2604257. doi: 10.1001/jamapediatrics.2016.5154 |
| PMID: 28241262 |
| Protocols and characterization data for 2D, 3D, and slice-based tumor models from the PREDECT project. |
| de Hoogt R, Estrada MF, Vidic S, Davies EJ, Osswald A, Barbier M, Santo VE, Gjerde K, van Zoggel HJAA, Blom S, Dong M, Närhi K, Boghaert E, Brito C, Chong Y, Sommergruber W, van der Kuip H, van Weerden WM, Verschuren EW, Hickman J, Graeser R |
| Scientific data. 2017 Nov 21. pii: sdata2017170. doi: 10.1038/sdata.2017.170 |
| PMID: 29160867 |
| Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma. |
| Klikovits T, Stockhammer P, Laszlo V, Dong Y, Hoda MA, Ghanim B, Opitz I, Frauenfelder T, Nguyen-Kim TDL, Weder W, Berger W, Grusch M, Aigner C, Klepetko W, Dome B, Renyi-Vamos F, Oehler R, Hegedus B |
| Scientific reports. 2017 Nov 28. doi: 10.1038/s41598-017-16551-7. pii: 10.1038/s41598-017-16551-7 |
| PMID: 29184132 |
| Plasmodium falciparum Falcipain-2a Polymorphisms in Southeast Asia and Their Association with Artemisinin Resistance. |
| Siddiqui FA, Cabrera M, Wang M, Brashear A, Kemirembe K, Wang Z, Miao J, Chookajorn T, Yang Z, Cao Y, Dong G, Rosenthal PJ, Cui L |
| The Journal of infectious diseases. 2018 Apr 12. pii: 4969222. doi: 10.1093/infdis/jiy188 |
| PMID: 29659945 |
| Flagellum inheritance in requires a kinetoplastid-specific protein phosphatase. |
| Zhou Q, Dong G, Li Z |
| The Journal of biological chemistry. 2018 Apr 17. pii: RA118.002106. doi: 10.1074/jbc.RA118.002106 |
| PMID: 29666191 |
| Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial. |
| Han B, Li K, Wang Q, Zhang L, Shi J, Wang Z, Cheng Y, He J, Shi Y, Zhao Y, Yu H, Zhao Y, Chen W, Luo Y, Wu L, Wang X, Pirker R, Nan K, Jin F, Dong J, Li B, Sun Y |
| JAMA oncology. 2018 Aug 9. pii: 2696341. doi: 10.1001/jamaoncol.2018.3039 |
| PMID: 30098152 |
| 43 Einträge | 1, 2, 3 › » |
Seite 1 / 3
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
